Acute quadriparesis revealing Gitelman syndrome: a case report
Open Access
- 10 June 2026
- journal article
- case report
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 88 (7) , 4583-4590
Abstract
Introduction and importance: Gitelman syndrome (GS) is a rare autosomal recessive renal tubulopathy caused by SLC12A3 gene mutations, leading to hypokalemia, metabolic alkalosis, hypomagnesemia, and hypocalciuria. Its estimated prevalence ranges from 1 to 10 per 40 000 individuals worldwide, with a carrier frequency approaching 1%, underscoring its potential public health relevance despite underdiagnosis. This case highlights a rare presentation of GS with acute quadriparesis mimicking neurological emergencies, emphasizing the risk of misdiagnosis in acute care settings. Case presentation: A 30-year-old female presented with acute-onset fever, vomiting, and progressive quadriparesis. Examination revealed flaccid paralysis (power: 2/5), areflexia, and bulbar weakness. Critical biochemical findings included severe hypokalemia (K + : 1.6 mmol/l), hypomagnesemia (1.19 mg/dl), metabolic alkalosis (pH: 7.48, HCO 3 − : 32 mEq/l), hypocalciuria (6.43 mg/24 h), low urinary potassium, and elevated serum renin. Clinical discussion: This case demonstrates an intercurrent illness that precipitated acute decompensation in previously undiagnosed GS, leading to profound weakness mimicking Guillain–Barré syndrome, periodic paralysis and Bartter syndrome. The key to diagnosis lies in recognizing the distinctive biochemical triad of hypokalemia, hypomagnesemia, and hypocalciuria with renal potassium wasting. Although genetic testing for SLC12A3 mutations remains the diagnostic gold standard, it is often unavailable in resource-limited settings, making biochemical recognition crucial. Conclusion: GS is a great mimicker that can present with acute severe paralysis. Clinicians must include it in the differential for unexplained hypokalemia and metabolic alkalosis, as prompt recognition and management with magnesium and potassium supplementation are crucial to prevent life-threatening arrhythmias, recurrent paralysis and reduce long-term morbidity.Keywords
This publication has 25 references indexed in Scilit:
- The role of genomics and proteomics in drug discovery and its application in pharmacyDiscover Applied Sciences, 2025
- Renal calcium and magnesium handling during pregnancy: modeling and analysisAmerican Journal of Physiology-Renal Physiology, 2024
- An early onset Gitelman syndrome presenting in a boy with failure to thrive with recurrent hypokalemia and hypomagnesemia: a case reportPan African Medical Journal, 2024
- An Overlooked Cause of HypokalemiaThe American Journal of Medicine, 2017
- Gitelman syndrome: consensus and guidance from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies ConferenceKidney International, 2017
- Mineralocorticoid receptor antagonists—pharmacodynamics and pharmacokinetic differencesCurrent Opinion in Pharmacology, 2016
- Differential diagnosis of Bartter syndrome, Gitelman syndrome, and pseudo–Bartter/Gitelman syndrome based on clinical characteristicsGenetics in Medicine, 2016
- Gitelman syndrome: pathophysiological and clinical aspectsQJM: An International Journal of Medicine, 2010
- Gitelman’s syndrome: towards genotype-phenotype correlations?Pediatric Nephrology, 2007
- Gitelman's syndrome revisited: An evaluation of symptoms and health-related quality of lifeKidney International, 2001